Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

REGENXBIO Total Assets 2014-2020 | RGNX

REGENXBIO total assets from 2014 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
REGENXBIO Annual Total Assets
(Millions of US $)
2019 $498
2018 $544
2017 $199
2016 $173
2015 $221
2014 $3
2013 $3
REGENXBIO Quarterly Total Assets
(Millions of US $)
2020-06-30 $450
2020-03-31 $464
2019-12-31 $498
2019-09-30 $509
2019-06-30 $529
2019-03-31 $519
2018-12-31 $544
2018-09-30 $515
2018-06-30 $336
2018-03-31 $317
2017-12-31 $199
2017-09-30 $209
2017-06-30 $224
2017-03-31 $224
2016-12-31 $173
2016-09-30 $196
2016-06-30 $206
2016-03-31 $215
2015-12-31 $221
2015-09-30 $227
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2013-12-31 $3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.009B $0.035B
REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; RGX-111, for the treatment of Mucopolysaccharidosis Type I which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system; RGX-121, for the treatment of Mucopolysaccharidosis Type II; RGX-314, for the treatment of wet age-related macular degeneration and RGX-321, for the treatment of X-linked retinitis pigmentosa. REGENXBIO Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.210B 10.56
Amgen (AMGN) United States $135.354B 14.70
CSL (CSLLY) Australia $97.716B 0.00
Gilead Sciences (GILD) United States $75.913B 10.93
Regeneron Pharmaceuticals (REGN) United States $61.349B 23.46
Vertex Pharmaceuticals (VRTX) United States $55.881B 31.18
Illumina (ILMN) United States $46.784B 54.40
Biogen (BIIB) United States $42.289B 7.24
Seattle Genetics (SGEN) United States $34.455B 0.00
Moderna (MRNA) United States $28.138B 0.00
BeiGene (BGNE) Cayman Islands $27.181B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.177B 11.32
Genmab (GMAB) Denmark $23.448B 14.79
Genmab (GNMSF) Denmark $22.360B 5.15
BioNTech SE (BNTX) Germany $21.348B 0.00
Immunomedics (IMMU) United States $20.276B 0.00
Incyte (INCY) United States $19.532B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.071B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.404B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Exact Sciences (EXAS) United States $15.470B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.342B 35.90
BioMarin Pharmaceutical (BMRN) United States $14.129B 102.51
ARGENX SE-ADR (ARGX) Netherlands $12.342B 0.00
QIAGEN (QGEN) Netherlands $11.861B 30.10
MyoKardia (MYOK) United States $11.791B 0.00
Sarepta Therapeutics (SRPT) United States $10.795B 0.00
Bio-Techne Corp (TECH) United States $10.198B 69.97
Guardant Health (GH) United States $10.133B 0.00
Repligen (RGEN) United States $9.056B 143.74
Galapagos (GLPG) Belgium $8.611B 31.16
Mirati Therapeutics (MRTX) United States $8.420B 0.00
Ascendis Pharma (ASND) Denmark $8.244B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.487B 231.96
Exelixis (EXEL) United States $6.881B 25.02
Acceleron Pharma (XLRN) United States $6.713B 0.00
Adaptive Biotechnologies (ADPT) United States $6.549B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.498B 0.00
Novavax (NVAX) United States $6.027B 0.00
Blueprint Medicines (BPMC) United States $5.664B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.577B 15.24
Ultragenyx Pharmaceutical (RARE) United States $5.453B 0.00
Emergent Biosolutions (EBS) United States $5.118B 20.27
NeoGenomics (NEO) United States $4.721B 1425.00
Vir Biotechnology (VIR) United States $4.505B 0.00
Arena Pharmaceuticals (ARNA) United States $4.484B 0.00
China Biologic Products (CBPO) China $4.472B 26.55
Denali Therapeutics (DNLI) United States $4.397B 0.00
Amicus Therapeutics (FOLD) United States $4.393B 0.00
Fate Therapeutics (FATE) United States $4.185B 0.00
Halozyme Therapeutics (HALO) United States $4.141B 0.00
Twist Bioscience (TWST) United States $3.964B 0.00
Insmed (INSM) United States $3.908B 0.00
Reata Pharmaceuticals (RETA) United States $3.885B 0.00
Bluebird Bio (BLUE) United States $3.642B 0.00
Global Blood Therapeutics (GBT) United States $3.598B 0.00
MorphoSys AG (MOR) Germany $3.538B 46.36
Legend Biotech (LEGN) United States $3.514B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.346B 0.00
Eidos Therapeutics (EIDX) United States $2.826B 0.00
Alkermes (ALKS) Ireland $2.691B 56.40
PHARMA MAR SA (PHMMF) Spain $2.604B 0.00
Seres Therapeutics (MCRB) United States $2.410B 0.00
I-Mab (IMAB) China $2.318B 0.00
Sorrento Therapeutics (SRNE) United States $2.151B 0.00
Editas Medicine (EDIT) United States $2.066B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.012B 0.00
Zymeworks (ZYME) Canada $1.974B 0.00
Amarin (AMRN) Ireland $1.908B 0.00
Inovio Pharmaceuticals (INO) United States $1.843B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Northwest Biotherapeutics (NWBO) United States $1.817B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Viela Bio (VIE) United States $1.736B 0.00
Intra-Cellular Therapies (ITCI) United States $1.732B 0.00
Revance Therapeutics (RVNC) United States $1.652B 0.00
Zealand Pharma (ZEAL) Denmark $1.604B 0.00
Beam Therapeutics (BEAM) United States $1.580B 0.00
Sangamo Therapeutics (SGMO) United States $1.494B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Intellia Therapeutics (NTLA) United States $1.430B 0.00
Ligand Pharmaceuticals (LGND) United States $1.426B 48.22
Dicerna Pharmaceuticals (DRNA) United States $1.424B 0.00
Epizyme (EPZM) United States $1.397B 0.00
Mesoblast (MESO) Australia $1.393B 0.00
Arcus Biosciences (RCUS) United States $1.255B 0.00
Alcobra (ARCT) United States $1.226B 0.00
Coherus BioSciences (CHRS) United States $1.198B 6.98
Mersana Therapeutics (MRSN) United States $1.183B 0.00
Cytokineticsorporated (CYTK) United States $1.146B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.145B 0.00
NGM Biopharmaceuticals (NGM) United States $1.127B 0.00
Retrophin (RTRX) United States $1.061B 0.00
Compugen (CGEN) Israel $1.004B 0.00
Myriad Genetics (MYGN) United States $1.003B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.002B 0.00
Genetron Holdings (GTH) China $0.996B 0.00
Heska (HSKA) United States $0.986B 0.00
Athenex (ATNX) United States $0.976B 0.00
Castle Biosciences (CSTL) United States $0.968B 0.00
Adverum Biotechnologies (ADVM) United States $0.941B 0.00
Vericel (VCEL) United States $0.938B 0.00
NantKwest (NK) United States $0.912B 0.00
Codexis (CDXS) United States $0.831B 0.00
Arvinas (ARVN) United States $0.823B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.820B 0.00
Intrexon (PGEN) United States $0.809B 0.00
Pliant Therapeutics (PLRX) United States $0.808B 0.00
Morphic Holding (MORF) United States $0.805B 0.00
Cellectis S.A (CLLS) France $0.768B 0.00
Agenus (AGEN) United States $0.759B 0.00
Alector (ALEC) United States $0.745B 0.00
Protagonist Therapeutics (PTGX) United States $0.741B 0.00
MiMedx (MDXG) United States $0.718B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.701B 0.00
Cara Therapeutics (CARA) United States $0.697B 0.00
Frequency Therapeutics (FREQ) United States $0.695B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
Sinovac Biotech (SVA) China $0.640B 43.13
Celldex Therapeutics (CLDX) United States $0.637B 0.00
Kadmon Holdings (KDMN) United States $0.635B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.630B 0.00
VBI Vaccines (VBIV) United States $0.603B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Geron (GERN) United States $0.574B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.562B 4.92
Cel-Sci (CVM) United States $0.532B 0.00
IVERIC Bio (ISEE) United States $0.527B 0.00
Albireo Pharma (ALBO) United States $0.523B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.520B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.520B 0.00
Anika Therapeutics (ANIK) United States $0.513B 22.44
Clovis Oncology (CLVS) United States $0.505B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.486B 0.00
MeiraGTx Holdings (MGTX) United States $0.483B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.471B 0.00
MannKind (MNKD) United States $0.461B 0.00
Avid Bioservices (CDMO) United States $0.459B 0.00
Dynavax Technologies (DVAX) United States $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Prothena (PRTA) Ireland $0.449B 0.00
Kala Pharmaceuticals (KALA) United States $0.437B 0.00
Sutro Biopharma (STRO) United States $0.433B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.433B 0.00
Amryt Pharma (AMYT) United Kingdom $0.433B 0.00
Starpharma Holdings (SPHRY) Australia $0.431B 0.00
Cue Biopharma (CUE) United States $0.417B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Forte Biosciences (FBRX) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.382B 0.00
Kamada (KMDA) Israel $0.377B 18.00
Puma Biotechnology (PBYI) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.374B 0.00
Trevena (TRVN) United States $0.366B 0.00
Syros Pharmaceuticals (SYRS) United States $0.360B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
IBio (IBIO) United States $0.352B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 8.13
Spero Therapeutics (SPRO) United States $0.344B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.342B 0.00
BioDelivery Sciences (BDSI) United States $0.334B 23.64
AC Immune SA (ACIU) Switzerland $0.334B 0.00
Precision BioSciences (DTIL) United States $0.333B 0.00
Athersys (ATHX) United States $0.322B 0.00
NextCure (NXTC) United States $0.317B 0.00
Cardiff Oncology (CRDF) United States $0.316B 0.00
Innate Pharma S.A (IPHA) France $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
ChromaDex (CDXC) United States $0.304B 0.00
WAVE Life Sciences (WVE) Singapore $0.302B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.301B 0.00
Pluristem Therapeutics (PSTI) Israel $0.274B 0.00
Affimed (AFMD) Germany $0.258B 0.00
PDL BioPharma (PDLI) United States $0.252B 0.00
Selecta Biosciences (SELB) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
Arbutus Biopharma (ABUS) United States $0.233B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
XOMA (XOMA) United States $0.219B 0.00
Verastem (VSTM) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Five Prime Therapeutics (FPRX) United States $0.208B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Dyadic (DYAI) United States $0.192B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.192B 0.00
Eton Pharmaceuticals (ETON) United States $0.191B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
CorMedix Inc (CRMD) United States $0.179B 0.00
Cerecor (CERC) United States $0.178B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.174B 0.00
DBV Technologies S.A (DBVT) France $0.174B 0.00
Biofrontera AG (BFRA) Germany $0.170B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Theratechnologies (THTX) Canada $0.166B 0.00
Kindred Biosciences (KIN) United States $0.163B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
Exicure (XCUR) United States $0.155B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.150B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Prometic Life Sciences (LMNL) Canada $0.149B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.148B 6.90
Checkpoint Therapeutics (CKPT) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.145B 0.00
SESEN BIO, INC (SESN) United States $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
AquaBounty Technologies (AQB) United States $0.133B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.122B 0.00
Windtree Therapeutics (WINT) United States $0.120B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Celyad SA (CYAD) Belgium $0.117B 0.00
Unum Therapeutics (COGT) United States $0.117B 0.00
Strongbridge Biopharma (SBBP) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.112B 0.00
Orgenesis (ORGS) United States $0.111B 5.66
Gritstone Oncology (GRTS) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.108B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.104B 0.00
AIT Therapeutics (XAIR) United States $0.103B 0.00
Oncobiologics (OTLK) United States $0.103B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.097B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 74.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Appili Therapeutics (APLIF) Canada $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
AmpliPhi Biosciences (ARMP) United States $0.065B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Curis (CRIS) United States $0.064B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Novogen (KZIA) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.039B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00